Showing results (171-180 of 3,162) with videos related to
Sort By:
Pageof 317
Translational Oncology|January 12, 2025
3-Hydroxyanthranic acid inhibits growth of oral squamous carcinoma cells through growth arrest and DNA damage inducible alphaGuifang Gan, Xinxia Zhou, Qiaoping Zheng, et al.Translational Oncology|January 3, 2025
ATM in immunobiology: From lymphocyte development to cancer immunotherapyJi-Hoon LeeTranslational Oncology|December 29, 2024
PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradationYaoxu Li, Bing Li, Kai Yang, et al.Translational Oncology|December 29, 2024
Exploration of the mechanism of 5-Methylcytosine promoting the progression of hepatocellular carcinomaQiyao Zhang, Zhen Cao, Yuting He, et al.Translational Oncology|December 28, 2024
Acetylation of E2F1 at K125 facilitates cell apoptosis under serum stressZejun Fang, Chaoju Gong, Yanyan Hu, et al.Translational Oncology|December 30, 2024
Prognostic implications of immune classification based on PD-L1 expression and tumor-infiltrating lymphocytes in endocervical adenocarcinomaLi-Jun Wei, Zi-Yun Wu, Li-Yan Wu, et al.Translational Oncology|March 25, 2025
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancerXianjiang Wu, Lei Dai, Weidong Zhang, et al.Translational Oncology|March 9, 2025
Comprehensive assessment of serum 3'-tRFArg as a novel diagnostic biomarker for gastric cancerRui Ding, Yang Li, Yu Zhang, et al.Translational Oncology|March 14, 2025
Single cell analysis reveals that SPP1+ macrophages enhance tumor progression by triggering fibroblast extracellular vesiclesHaocheng Wang, Bowen Qiu, Xinyu Li, et al.Translational Oncology|March 9, 2025
Immunomodulation on tumor immune microenvironment in acquired targeted therapy resistance and implication for immunotherapy resistanceMing-Yu Chou, Muh-Hwa YangPageof 317